🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 44486Q103 (prev. 020751103 )
- Market Cap
- Mid Cap
- IPO
- 9/18/2020
- Previous Symbol
- AHAC (changed 8/27/2021)
- Previous Name
- Alpha Healthcare Acquisition Corp
Business: Humacyte, Inc. develops and manufactures acellular tissues to treat a wide range of diseases, injuries and chronic conditions. Humacyte’s initial opportunity, a portfolio of human acellular vessels (HAVs), is currently in late-stage clinical trials targeting multiple vascular applications, including vascular trauma repair, arteriovenous access for hemodialysis, and peripheral arterial disease.
Company Contact
- CEO
- Laura E. Niklason
- CFO
- Dale Sander
- Headquarters
- 2525 East North Carolina Highway 54, Durham NC 27713
- Phone
- 919-313-9633
- Investor Relations
- 919-313-9633 · investors@humacyte.com